[Home ] [Archive]    
:: Main About journal Editorial Board Current Issue Archive Submit an article Site Map Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 6, Issue 4 (12-2017) ::
Int J Med Invest 2017, 6(4): 176-185 Back to browse issues page
Comparing effect of oxytocin versus oxytocin-propranolol combination on labor progression
Elahe Amiri , Maryam Yazdani , Somayyeh Noei Teymoordash * , Amir Hossein Salimi Kordasiabi
Obstetrics and Gynecology, Research & Development Center Hospital Sayyed Shirazi, Golestan University of Medical Sciences, Golestan, Iran
Abstract:   (7291 Views)
Introduction: Elective induction of labor increase the risk of cesarean section rate. pharmacological methods Including prostaglandins and oxytocin that are used. Another thing that may be helpful in the process of induction (propranolol), which is a type 1 and 2 beta-adrenergic receptor blocker. Stimulation of these receptors inhibits uterine contractions. Due to the inconsistent results from different studies as well as the small number of studies in this field, and the importance of the potential side effects of high doses of oxytocin on the health of the mother and fetus, this study aimed to evaluate the use of propranolol plus oxytocin compared with oxy oxytocin alone on the progress of the delivery. Methods: This study was a controlled double-blind clinical trial, and 50 cases in each group. inclusion and exclusion criteria were considered. In Group oxytocin, oxytocin was started in 2 mIu / ml, and every 15 minutes in the same amount was added to the good contractions (three good contractions in 10 min), respectively, then 8 hours continued. In the propranolol group, before induction, 2 mg propranolol intravenously and slowly at a speed of 1 mg per minute were injected and then with oxytocin induction was established as above. Delivery and patient follow-up data were recorded. Findings: In our study, the effect of propranolol on labor were investigated, propranolol has been able to reduce the duration of latent phase in the case group than the control group. (P =0.000). The mean duration of the active phase and second stage of labor were studied in two groups was not statistically significant, (P =0.703) for the duration of the active phase and (P =0.509) for the second stage of labor. In our study delivery and the cause of cesarean delivery and Apgar score at 5 minutes’ infants were compared. in our study, the cesarean rate in the control group was higher, but the difference was not statistically significant (P =0.106). Conclusion: In total, according to the studies and research it seems that propranolol can be used to help labor.
Keywords: propranolol, oxytocin, labor
Full-Text [PDF 806 kb]   (2559 Downloads)    
Type of Study: Research | Subject: General
References
1. 1- Cunningham FG. Leveno KJ. Bloom SL. Hauth JC. Gilstrap III. et al. Williams Obstetrics. 22 ed. MC Graw- Hill: New York: 2005. p. 536-537. 2- Mobasheri E, Jafarpour H, Rezaei A, Piraste Far Z, Bakhshi T. The Role Of Antibiotics Therapy On Maternal Complication In Women With Premature Rupture Of Membranes. 2017; 6(2): 53-58 3- Maslow AS. Sweeny AL. Elective induction of labor as a risk factor for cesarean delivery among low-risk women at term. Obstet Gyneocol 2000; 95: 917-922. 4- Smith KM. Hoffman MK. Sciscione A. Elective induction of labor in nulliparous women increases the risk of cesarean delivery. Obstet Gynecol 2003; 101: 455. 5- Hinshaw K, Simpson S, Cummings S, Hildreth A, Thornton J. A Andomized Controlled Trial Of Early Versus Delayed Oxytocin Augmentation To Treat Primary Dysfunctional Labour In Nulliparous Women. BJOG 2008; 115(10):1289-95. 6- American College of Obstetrics, Gynecology Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin Number 49, December 2003; Dystocia and Augmentation of Labor. Obstet Gynecol 2003; 102:1445- 54. 7- O’Driscoll K, Foley M, Macdonald D. Active Management of Labor as an Alternative to Cesarean Section for Dystocia. Obstet Gynecol 1984; 63:485-90. 8- Schuitemaker N, Van Roosmalen J, Dekker G, Van Dongen P, Van Geijn H, Gravenhorst JB. Maternal Mortality after Cesarean Section in the Netherlands. Acta Obstet Gynecol Scand 1997; 76:332 4. 9- Hemlin J. Moller B. Extraamniotic saline infusion is promising in preparing the cervix for induction of labor. Acta Obstet Gynecol Scand 1998; 77: 45-9. 10- Kashanian M, Zarin Z . Comparison of the effect of oxytocin alone and the administration of oxytocin-propranolol on the onset of labor - A randomized, double-blind study. Feyz Scientific-Research Quarterly. 10 (2): 7-11 11- Sharami S. H, et al. Effect of Oxytocin Plus Propranolol on The Success of Labor Augmentation. Journal of Guilan University of Medical Sciences, No: 82, Pages: 57-64 12- Ashraf Direkvand Moghadam et al., Comparison Effect of Oral Propranolol and Oxytocin Versus Oxytocin only on Induction of Labor, Journal of Clinical and Diagnostic Research. 2013 Nov, Vol-7(11): 2567-2569 13- Direkvand-Moghadam A, Jaafarpour M, Khani A, Taheri S, Delpisheh A. Theeffect of oral propranolol plus oxytocin versus oxytocin only on the process and outcome of labor: A double-blind randomized trial. Iran J Nurs Midwifery Res. 2014 Sep;19(5):491-5. 14- Ziółkowski K. Induction of Labor in Prolonged Pregnancy with Propranolol as a Personal Evaluation. Pol Tyg Lek 1994; 49(8-9):184-5. 15- Palomäki O, Uotila J, Tammela O, Kaila T, Lavapuro M, Huhtala H, Tuimala R. A Double Blind, Randomized Trial on Augmentation of Labour with A Combination of Intravenous Propranolol and Oxytocin Versus Oxytocin Only. Eur J Obstet Gynecol Reprod Biol 2006; 125(1):44-9. 16- Mitrani A, Oettinger M, Abinader EG, Sharf M, Klein A. Use of Propranolol in Dysfunctional Labour. Br J Obstet Gynaecol 1975; 82(8):651-5. 17- Flier JS. Underhill LH. Adrenergic Receptors- Evolving Concepts and Clinical Implications. N Engl J Med 1996; 334: 580. 18- Dennedy MC. Houlihan DD. Mc Millan H. Morrison JJ. Beta 2-and beta3- adrenoreceptor agonists: human Myometrial selectivity and effects on umbilical artery tone. Am J Obstet Gynecol 2002; 187: 641-647. 19- Chanrachakul B. Matharoo-Ball B. Turner A. Robinson G. Broughton-Pipkin F. Arulkumaran S. et al. Reduced expression of immunoreactive beta2-adrenergic receptor protein in human myometrium with labor. J Clin Endocrinol Metab 2003; 88: 4997-5001. 20- Bardou M. Loustalot C. Cortijo J. Simon B. Naline E. Dumas M. Et al. Functional, biochemical and molecular biological evidence for a possible beta (3)-adrenoceptor in human near-term myometrium. Br J Pharmacol 2000; 130: 1960-1966. 21- Rouget C. Bardou M. Breuiller- Fouche M. Loustalot C. Qi H. Naline E. Et al. Beta 3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy. J Clin Endocrinol Metab 2005; 90: 1644-1650. 22- Ingarden J. Dubiel A. Rauluszkiewicz S. The effect of administration of a beta blocker in periparturient mares. Equine Vet J Suppl 1998; 27: 19-20. 23- Pergialiotis V, Frountzas M, Prodromidou A, Prapa S, Perrea DN, Vlachos GD. Propranolol and oxytocin versus oxytocin alone for induction and augmentation of labor: a meta-analysis of randomized trials. Arch Gynecol Obstet. 2016 Apr;293(4):721-9. 24- Outi Paloma¨ki , Jukka Uotila , Outi Tammela , Timo Kaila, Merja Lavapuro , Heini Huhtala , Risto Tuimala. A double blind, randomized trial on augmentation of labour with a combination of intravenous propranolol and oxytocin versus oxytocin only. European Journal of Obstetrics & Gynecology and Reproductive Biology 125 (2006) 44–49. 25- American College of Obstetrics, Gynecology Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin number 49, December 2003: dystocia and augmentation of labor. Obstet Gynecol 2003;102:1445–54. 26- Ha¨ger RM, Daltveit AK, Hofoss D, Nilsen ST, Kolaas T, Oian P, et al.Complications of Cesarean deliveries: rates and risk factors. Am J Obstet Gynecol 2004;190:428–34. 27- Jackson N, Paterson-Brown S. Physical sequelae of caesarean section. Best Pract Res Clin Obstet Gynaecol 2001;15:49–61. 28- Schuitemaker N, van Roosmalen J, Dekker G, van Dongen P, van Geijn H, Gravenhorst JB. Maternal mortality after Cesarean section in the Netherlands. Acta Obstet Gynecol Scand 1997;76:332–4. 29- Sanchez-Ramos L, Quillen MJ, Kaunitz AM. Randomized trial of oxytocin alone and with propranolol in the management of dysfunctional labor. Obstet Gynecol 1996;88:517–20. 30- Katzung BG. Clinical Pharmacology. Philadelphia; Appletone, 1998.
Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amiri E, Yazdani M, Noei Teymoordash S, Salimi Kordasiabi A H. Comparing effect of oxytocin versus oxytocin-propranolol combination on labor progression. Int J Med Invest 2017; 6 (4) :176-185
URL: http://intjmi.com/article-1-293-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 4 (12-2017) Back to browse issues page
International Journal of Medical Investigation
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645